EFFICACY AND SAFETY OF PROTON PUMP INHIBITORS (PPIS) FOR STRESS ULCER PROPHYLAXIS: A SYSTEMATIC REVIEW
ARACÊ · 06.08.2026 · 8 (8) · e13980
DOI: 10.56238/arev8n8-028 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift ARACÊ, online erschienen am 06.08.2026. Verfasst von Bruno Biths Batista und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Stress ulcer prophylaxis is widely used in critically ill patients to prevent clinically relevant gastrointestinal bleeding. Proton pump inhibitors (PPIs), such as omeprazole and esomeprazole, are commonly used in this practice. However, their indiscriminate use has been associated with adverse events, including Clostridioides difficile infections and nosocomial pneumonia, as well as uncertainties regarding their benefits in non-critical populations.
Objective
To evaluate the efficacy and safety of PPIs for the prophylaxis of clinically relevant gastrointestinal bleeding in critically ill and non-critically ill patients.
Methods
A systematic review without meta-analysis was conducted according to PRISMA guidelines. The PubMed, Web of Science, Virtual Health Library (VHL), CAPES Journals, LILACS, and EMBASE databases were searched. The study was registered in PROSPERO (CRD442025640517), using the descriptors “Prophylaxis”, “Stress Ulcer”, “Critical Care”, and “Proton Pump Inhibitor”. Studies published in English and Portuguese between 2014 and 2024 were included.
Results
PPIs demonstrated benefits in reducing gastrointestinal bleeding among high-risk critically ill patients, whereas their effectiveness in non-critical populations remains limited. Inappropriate use was associated with an increased risk of infectious complications, highlighting the importance of clinical criteria and institutional protocols.
Conclusion
PPI prophylaxis should be targeted to patients with well-established clinical indications, particularly critically ill individuals at high risk. Individualized assessment and the implementation of care protocols are essential to balance benefits and risks.
Zitieren
APA
Batista, B. B., Silva, I. A. D. A., Araripe, D. T. R., Araripe, M. V. R., Santos, A. V. R. D., Silva, I. D. J. F., Leitão, F. N. C., & Azenha, K. M. R. (2026). EFFICACY AND SAFETY OF PROTON PUMP INHIBITORS (PPIS) FOR STRESS ULCER PROPHYLAXIS: A SYSTEMATIC REVIEW. ARACÊ, 8(8), e13980. https://doi.org/10.56238/arev8n8-028
Vancouver
Batista BB, Silva IADA, Araripe DTR, Araripe MVR, Santos AVRD, Silva IDJF, et al. EFFICACY AND SAFETY OF PROTON PUMP INHIBITORS (PPIS) FOR STRESS ULCER PROPHYLAXIS: A SYSTEMATIC REVIEW. ARACÊ. 2026;8(8):e13980. doi:10.56238/arev8n8-028
BibTeX
@article{Batista2026,
author = {Batista, Bruno Biths and Silva, Italo Assunção de Andrade and Araripe, Daniella Talita Ruppel and Araripe, Marcus Vinicius Ruppel and Santos, Amanda Vitória Rodrigues dos and Silva, Isabelly Della Justina Florentino and Leitão, Francisco Naildo Cardoso and Azenha, Kizzy Montini Ramos},
title = {EFFICACY AND SAFETY OF PROTON PUMP INHIBITORS (PPIS) FOR STRESS ULCER PROPHYLAXIS: A SYSTEMATIC REVIEW},
journal = {ARACÊ},
year = {2026},
volume = {8},
number = {8},
pages = {e13980},
doi = {10.56238/arev8n8-028}
}
EUVIMED